Surgery Center Holdings has wrapped up its $792 million acquisition of locally based competitor Symbion. The combined company will generate total revenues of more than $900 million from facilities in 26 states. As part of the deal, CEO Richard Francis and President and COO Cliff Adlerz have resigned from their positions, starting the clock on their noncompete and nonsolicitation agreements.
The fact that AmSurg shares (Ticker: AMSG) are trading at all-time highs hasn't escaped the attention of Executive Vice President David Manning. A trading plan set up last fall by the veteran development exec on Monday exercised about 12,000 stock options that would have expired in 2017 and then sold the resulting shares. His profit on the transactions tops $345,000.
POSTDATA: WARRANTY DEEDS